This article offers sharp spatial and temporal mean-square regularity results for a class of semi-linear parabolic stochastic partial differential equations (SPDEs) driven by infinite dimensional fractional Brownian motion with the Hurst parameter greater than one-half. In addition, mean-square numerical approximation of such problem are investigated, performed by the spectral Galerkin method in space and the linear implicit Euler method in time. The obtained sharp regularity properties of the problems enable us to identify optimal mean-square convergence rates of the full discrete scheme. These theoretical findings are accompanied by several numerical examples.
In this paper, we first prove the strong convergence of the split-step theta methods for non-autonomous stochastic differential equations under a linear growth condition on the diffusion coefficient and a onesided Lipschitz condition on the drift coefficient. Then, if the drift coefficient satisfies a polynomial growth condition, we further get the rate of convergence. Finally, the obtained results are supported by numerical experiments.
In this work, we propose two classes of two-step Milstein type schemes : the double-implicit Milstein scheme and the split two-step Milstein scheme, to solve stochastic differential equations. Our results reveal that the two new schemes are strong convergent with order one. Moreover, with a restriction on stepsize, these two schemes can preserve the exponential mean square stability of the original stochastic differential equations, and the decay rate of numerical solution will converge to the the decay rate of the exact solution. Numerical experiments are performed to confirm our theoretic findings.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.